Concepedia

Nandini Kishore

NK

17

Publications

2.2K

Citations

16

H-Index

1996

Active since

Affiliations

Pfizer (United States)(Current)

University of Rochester Medical Center

American Pharmacists Association

Nandini Kishore is an author at Pfizer (United States) specializing in medicine, pharmacology, and drug discovery.

Top concepts

Publications per year

1996–2013

17

Publications

17

Modulation of Innate and Adaptive Immune Responses by Tofacitinib (CP-690,550)

Kamran Ghoreschi, Michael I. Jesson, Li Xiong et al. · The Journal of Immunology · 2011 · 628 citations · Full text

Anti-inflammatory activity and neutrophil reductions mediated by the JAK1/JAK3 inhibitor, CP-690,550, in rat adjuvant-induced arthritis

Debra M. Meyer, Michael I. Jesson, Xiong Li et al. · Journal of Inflammation · 2010 · 455 citations · Full text

A Selective IKK-2 Inhibitor Blocks NF-κB-dependent Gene Expression in Interleukin-1β-stimulated Synovial Fibroblasts

Nandini Kishore, Cindy Sommers, Sumathy Mathialagan et al. · Journal of Biological Chemistry · 2003 · 273 citations · Full text

IKK-i and TBK-1 are Enzymatically Distinct from the Homologous Enzyme IKK-2

Nandini Kishore, Q K Huynh, Sumathy Mathialagan et al. · Journal of Biological Chemistry · 2002 · 144 citations · Full text

JAK inhibition with tofacitinib suppresses arthritic joint structural damage through decreased RANKL production

Timothy P. LaBranche, Michael I. Jesson, Chad Storer et al. · Arthritis & Rheumatism · 2012 · 130 citations

Rows per page

1–5 of 17